Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
ZNTL
#3078
Zentalis Pharmaceuticals, Inc. Common Stock
2.3
9
-0.42%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-0.42%
Variazione Mensile
-18.98%
Variazione di 6 mesi
+32.78%
Variazione Annuale
+17.73%
Chiusura Precedente
2.4
0
Open
2.3
9
Bid
Ask
Low
2.3
9
High
2.3
9
Volume
70
Mercati
Mercato Azionario Statunitense
Salute
ZNTL
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
Notizie
Zentalis Pharma CEO Eastland sells $21k in shares
Zentalis Pharma CMO Bruns sells $7998 in stock
Zentalis Pharmaceuticals: PAO vende azioni per 7.800 dollari
Zentalis Pharmaceuticals: Late Stage, Lots Of Cash, Crushed By The Market
Zentalis Pharmaceuticals: Hanging On For One Last Shot At PROC Approval (ZNTL)
Obiettivo di prezzo di Zentalis Pharmaceuticals ridotto a $2 da Leerink Partners
Zentalis Pharmaceuticals stock price target lowered to $2 at Leerink Partners
Zentalis to present azenosertib data at cancer therapeutics conference
Zentalis Pharmaceuticals shareholders elect three directors at annual meeting
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
H.C. Wainwright maintains buy rating on Zentalis stock after ASCO update
Zentalis Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Progress